Paroxysmal Dyskinesias Revealing 3-Hydroxy-Isobutyryl-CoA Hydrolase (HIBCH) Deficiency.


Journal

Neuropediatrics
ISSN: 1439-1899
Titre abrégé: Neuropediatrics
Pays: Germany
ID NLM: 8101187

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 29 1 2021
medline: 7 4 2022
entrez: 28 1 2021
Statut: ppublish

Résumé

Paroxysmal dyskinesias (PD) are rare movement disorders characterized by recurrent attacks of dystonia, chorea, athetosis, or their combination, with large phenotypic and genetic heterogeneity. 3-Hydroxy-isobutyryl-CoA hydrolase (

Identifiants

pubmed: 33506479
doi: 10.1055/s-0040-1722678
doi:

Substances chimiques

isobutyryl-coenzyme A 15621-60-0
Thiolester Hydrolases EC 3.1.2.-
3-hydroxyisobutyryl-CoA hydrolase EC 3.1.2.4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

410-414

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None of the authors has any conflict of interest to disclose.

Auteurs

Marie-Aude Spitz (MA)

Service de Pédiatrie 1, CHRU Strasbourg, Strasbourg, France.

Guy Lenaers (G)

Équipe Mitolab, Institut MITOVASC, INSERM U1083, CNRS 6015, Université d'Angers, Angers, France.

Majida Charif (M)

Équipe Mitolab, Institut MITOVASC, INSERM U1083, CNRS 6015, Université d'Angers, Angers, France.

Thomas Wirth (T)

Service de Neurologie, CHRU Strasbourg, Strasbourg, France.
Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), UMR 7104 CNRS/Unistra, INSERM U1258, Illkirch, France.
Unit of Functional Neurosurgery, National Hospital for Neurology and Neurosurgery, London, United Kingdom.

Jameleddine Chelly (J)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), UMR 7104 CNRS/Unistra, INSERM U1258, Illkirch, France.

Marie-Thérèse Abi-Warde (MT)

Service de Pédiatrie 1, CHRU Strasbourg, Strasbourg, France.

Pierre Meyer (P)

Département de Neuropédiatrie, CHU Gui de Chauliac, Montpellier, France.

Nicolas Leboucq (N)

Service de Neuroradiologie, Hôpital Gui de Chauliac, CHRU Montpellier, Montpellier, France.

Elise Schaefer (E)

Service de Génétique Médicale, CHRU Strasbourg, Strasbourg, France.

Mathieu Anheim (M)

Service de Neurologie, CHRU Strasbourg, Strasbourg, France.

Agathe Roubertie (A)

Département de Neuropédiatrie, CHU Gui de Chauliac, Montpellier, France.
INSERM U 1051, Institut des Neurosciences de Montpellier, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH